The New England Journal of Medicine published an article that is freely accessible online to the public and addresses the FDA?s perspectives on risks and benefits of 5?-reductase inhibitors for prostate-cancer prevention and the recent additions (warnings) to the product labels.
Link: The Risks and Benefits of 5?-Reductase Inhibitors for Prostate-Cancer Prevention
Of course, I am [...]
Source: http://www.baldingblog.com/2011/06/20/the-fdas-perspective-on-finasteride-risks/
No comments:
Post a Comment